Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
22.37
-0.69 (-2.99%)
At close: Mar 3, 2025, 4:00 PM
22.40
+0.03 (0.13%)
Pre-market: Mar 4, 2025, 7:20 AM EST
Rigel Pharmaceuticals Employees
Rigel Pharmaceuticals had 147 employees as of December 31, 2023. The number of employees decreased by 8 or -5.16% compared to the previous year.
Employees
147
Change (1Y)
-8
Growth (1Y)
-5.16%
Revenue / Employee
$1,070,571
Profits / Employee
$26,401
Market Cap
394.05M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
RIGL News
- 7 days ago - Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update - PRNewsWire
- 5 weeks ago - Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease - PRNewsWire
- 7 weeks ago - Rigel Provides Business Update and 2025 Outlook - PRNewsWire
- 7 weeks ago - Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS - PRNewsWire
- 7 weeks ago - Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 2 months ago - Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 2 months ago - Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents - Seeking Alpha
- 3 months ago - Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition - PRNewsWire